Navigation Links
Recurrent Gliomas: Vorinostat Shows Anti-cancer Activity

CHICAGO Findings presented today at the American Society of Clinical Oncology Annual Meeting by Eva Galanis, M.D., a Mayo Clinic oncologist, reveals that a novel application of the drug vorinostat shows activity in patients with recurrent glioblastoma multiforme. The study was conducted by North Central Cancer Treatment Group (NCCTG) researchers, based at Mayo Clinic in Rochester, Minn. Eva is the lead investigator of the study.

Glioblastoma multiforme is a lethal primary brain tumor. The average survival of glioblastoma patients is 12-16 months. These tumors spread quickly to other parts of the brain, and because of this are difficult to treat and often recur. When the tumor recurs, treatment options are limited, and patients survive for an average of three to four months.

"Existing treatment interventions have minimal impact on the outcome of recurrent glioblastoma multiforme patients," Dr. Galanis says. "Using vorinostat to treat glioblastoma multiforme patients who have relapsed following surgery, radiation and chemotherapy, we found that 15 percent of the patients had no tumor recurrence for six months or longer following treatment initiation. The median overall survival of the patients enrolled on the trial was 5.7 months -- similar patient populations enrolled in prior NCCTG trials had a median overall survival of between 4 and 4.4 months."

This study was the first application of vorinostat in targeting brain cancer. Vorinostat is approved by the U.S. Food and Drug Administration (FDA) for the treatment of cutaneous T cell lymphoma in patients who have failed two or more systemic therapies.

An additional group of patients in this study was treated with vorinostat prior to surgery, and a gene and protein analysis of their resected tumors was performed. This analysis confirmed increase in histone acetylation and showed gene changes indicating that vorinostat reaches the glioblastoma tumors and interferes
'"/>




Page: 1 2

Related medicine news :

1. Estrogen Does Not Prevent Recurrent Strokes
2. Radiation Therapy An Effective Solution For Recurrent Prostate Cancer
3. Prevention Of Recurrent Leg Ulcers
4. Measuring Urinary Protein Helps In Detecting Recurrent Bladder Cancer
5. Sertraline Can Prevent Recurrent Depressive Episodes In Diabetics
6. Angola Warned of Recurrent Cholera Outbreaks
7. Gemzar the New Drug for Recurrent Ovarian Cancer
8. Recurrent Stroke Risk is Minimized by Statin
9. Blood Markers Predict Risk for Recurrent Stroke and Mortality
10. Targeted Compound Helps Recurrent Prostate Cancer Patients
11. Ancient Indian Herb May Prove Cure For Recurrent UTI
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Recurrent Gliomas Vorinostat Shows Anti cancer Activity

(Date:7/7/2015)... New York (PRWEB) , ... July 07, 2015 , ... ... a wide array of charitable organizations on a local, national and international level; however, ... an organization they believe will have a high impact on the beneficiaries. In September ...
(Date:7/6/2015)... Woods, CA (PRWEB) , ... July 06, 2015 ... ... Water Revival System that eliminates 100% of all acids, chemicals and impurities; it ... suggested for drinking water because it contains harmful contaminants.  These harmful contaminants are ...
(Date:7/6/2015)... ... July 06, 2015 , ... Shortly after opening her second ... leading network of doctors working on a lien basis. Dr. Lim had previously ... The daughter of two Cambodian refugees, Dr. Lim suffered with back pain herself throughout ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... Olive Fertility ... the UBC 2014-2015 Post Graduate Teaching Award on behalf of the department of Family ... a very exciting field to be practicing in. The technology is changing so rapidly ...
(Date:7/6/2015)... ... 2015 , ... Seedstock today announced Pierre Sleiman, founder and CEO of ... Sustainable Agriculture Conference – “Innovation and the Small Farmer” – to be held Nov. ... California-San Diego, will explore solutions and methodologies that small farmers and entrepreneurs are developing ...
Breaking Medicine News(10 mins):Health News:The Holiday Inn Westbury - Long Island Will Host a Fundraising Event on September 16th 2015 from 6:00 pm - 10:00 pm to Benefit Angela's House located on Long Island 2Health News:The Holiday Inn Westbury - Long Island Will Host a Fundraising Event on September 16th 2015 from 6:00 pm - 10:00 pm to Benefit Angela's House located on Long Island 3Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4
... of a new malaria vaccine on both humans and ... disease that causes at least one million deaths annually, ... the Pasteur Institute here injected an MSP-3-based vaccine into ... it after one month and again after four months, ...
... from National Cancer Institute, US is to start testing their ... drug metabolize, enzyme kinetics and drug action mechanisms in dogs ... ,Dr. Chand Khanna, Veterinary Oncologist said, “It turns out that ... represented in dogs and the dogs will help us prioritize ...
... very good ones nutritionally due to their numerous benefits and ... of stroke, according to an article published in the Oct. ... of seven prospective studies, five from the US, one from ... of 232,049 subjects - 90,513 men and 141,536 women - ...
... new research conducted in Helsinki, Finland, gluten-free diet ... adolescents with coeliac disease.,Coeliac disease in adolescents has ... and disruptive behavioural disorders, particularly in the phase ... 9 adolescents with coeliac disease, aged 12 to ...
... There has been an increasing focus to change work ... and relaxation to avoid mental illness and its devastating ... acceptable one in view of the results published by ... the impact of anxiety and depressive disorders on workplace ...
... claimed to be of the first of its kind, ... in a young child with attention-deficit/hyperactivity disorder//. ... of the journal Pediatrics, present the case report of ... hyperactivity, attention deficit, impulsivity, and sleep problems. ...
Cached Medicine News:Health News:Breakthrough In New Vaccine For Malaria 2Health News:Servings of fruits can help reduce the risk of stroke 2Health News:Gluten-Free Diet May Alleviate Psychiatric Symptoms In Adolescents 2Health News:Now Employers Focus On Employees Mental health 2Health News:Iron Supplementation Aid In Relief From Attention-Deficit/Hyperactivity Disorder 2
(Date:7/6/2015)... -- Cardinal Health today announced the completion of the ... generic pharmaceuticals, over-the-counter medications and related products to retail, ... Court Square Capital Partners. The $1.115 billion acquisition was ... Headquartered in Livonia, Mich. ... approximately $450 million in 2014. There are 450 employees ...
(Date:7/6/2015)... and FARMINGTON, Conn. , July ... PTN), a biopharmaceutical company developing targeted, receptor-specific peptide ... unmet medical need and commercial potential, today announced ... of Series E warrants to purchase 21,917,808 shares ... to purchase 2,191,781 shares of its common stock.  ...
(Date:7/6/2015)...   Cepheid (Nasdaq: CPHD ) today announced ... second quarter ended June 30, 2015 on Thursday, July ... The Company will host a management presentation at ... to discuss the results.  To access the live webcast, ... least 15 minutes before the scheduled start time to ...
Breaking Medicine Technology:Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5
... 2011 Reportlinker.com announces that a new market ... A Global Overview of Herbal/Traditional Products ... The quest for "safer and natural" options ... recognising the benefits of traditional medicine, consumers are ...
... March 14, 2011 Reportlinker.com announces that a ... catalogue: Hepatitis A Preventive Vaccines ... http://www.reportlinker.com/p0453473/Hepatitis-A-Preventive-Vaccines---Pipeline-Assessment-and-Market-Forecasts-to-2017.html ... Market Forecasts to 2017 SummaryGlobalData, ...
Cached Medicine Technology:Reportlinker Adds A Global Overview of Herbal/Traditional Products 2Reportlinker Adds Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017 3
Inquire...
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
Inquire...
Medicine Products: